Literature DB >> 1679931

Biallelic ApaI polymorphism of the human p53 gene (TP53).

J Prosser1, A Condie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1679931      PMCID： PMC328764          DOI： 10.1093/nar/19.17.4799-a

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  2 in total

1.  Localization of gene for human p53 tumour antigen to band 17p13.

Authors:  M Isobe; B S Emanuel; D Givol; M Oren; C M Croce
Journal:  Nature       Date:  1986 Mar 6-12       Impact factor: 49.962

2.  Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.

Authors:  R Zakut-Houri; B Bienz-Tadmor; D Givol; M Oren
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598
  2 in total
  14 in total

1.  Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15.

Authors:  José Luis Soto Martínez; Carmen M Cabrera Morales; Sabio Serrano Ortega; Miguel Angel López-Nevot
Journal:  Clin Transl Oncol       Date:  2005-05       Impact factor: 3.405

Review 2.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  Germline mutations of TP53 gene in breast cancer.

Authors:  Surekha Damineni; Vadlamudi Raghavendra Rao; Satish Kumar; Rajasekar Reddy Ravuri; Sailaja Kagitha; Nageswara Rao Dunna; Raghunadharao Digumarthi; Vishnupriya Satti
Journal:  Tumour Biol       Date:  2014-06-15

4.  Feasibility of using decades-old archival tissues in molecular oncology/epidemiology.

Authors:  K S Iwamoto; T Mizuno; T Ito; M Akiyama; N Takeichi; K Mabuchi; T Seyama
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.

Authors:  Venkat R Katkoori; Xu Jia; Chandrakumar Shanmugam; Wen Wan; Sreelatha Meleth; Harvey Bumpers; William E Grizzle; Upender Manne
Journal:  Clin Cancer Res       Date:  2009-04-01       Impact factor: 12.531

6.  Detection of P53 tumor-suppressor-gene protein in bladder tumors and prostate cancer: possible clinical implications.

Authors:  M A Kuczyk; J Serth; C Hervatin; H Arndt; L Derendorf; W F Thon; U Jonas
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

7.  Characterization of novel and uncharacterized p53 SNPs in the Chinese population--intron 2 SNP co-segregates with the common codon 72 polymorphism.

Authors:  Beng Hooi Phang; Hui Wan Chua; Huihua Li; Yeh Ching Linn; Kanaga Sabapathy
Journal:  PLoS One       Date:  2011-01-10       Impact factor: 3.240

8.  Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.

Authors:  A Weston; J H Godbold
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

9.  Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B.

Authors:  José Luis Soto; Carmen M Cabrera; Salvio Serrano; Miguel Angel López-Nevot
Journal:  BMC Cancer       Date:  2005-04-08       Impact factor: 4.430

10.  p53 mutations and overexpression in locally advanced breast cancers.

Authors:  A Faille; P De Cremoux; J M Extra; G Linares; M Espie; E Bourstyn; A De Rocquancourt; S Giacchetti; M Marty; F Calvo
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.